Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety...
Search results for "Samsung Bioepis"
Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub
Samsung Bioepis announced on the 29th that it has signed a memorandum of understanding with Atlalt Innovation Center, a Chinese biotechnology R&D and...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January
Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...
Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe
Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original...
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year
Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe
Samsung Bioepis announced on the 4th that it has recovered the European commercialization rights for the ophthalmic...
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
1